潜在性結核感染検出の市場規模、シェア、動向分析レポート：ブランド別、検査タイプ別、用途別、最終用途別、地域別、セグメント別予測、2024年～2030年

潜在性結核感染検出市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の潜在性結核感染検出の市場規模は2030年までに26億3,000万米ドルに達する見込みです。

同市場は2024年から2030年にかけてCAGR 5.44％で拡大する見込みです。世界の高齢者人口の急増と相まって、潜在性結核感染症（LTBI）から活動性疾患を発症するリスクが高まっていることが、市場成長の主な促進要因の1つとなっています。加えて、結核検出に関する意識の高まりや、結核感染の効果的な診断とスクリーニングのための様々な政府の取り組みも、市場拡大に寄与する要因の一つです。例えば、2021年7月、UKHSAとイングランドNHSは、国内の結核患者を減少させるための5カ年計画を開始しました。

市場成長の原動力となっているのは、世界の高齢者人口の増加です。例えば、America's Health Rankings 2021の高齢者人口報告書によると、米国では65歳以上の人口が5,400万人を超え、同国の人口の16.5%を占めています。高齢者は潜在性結核に感染しやすいです。政策立案者や公衆衛生当局者は、国内の高齢者の健康を改善するための政策を改善しています。

さらに、結核の診断と検査を促進するための主要団体による継続的な資金援助活動も、市場の成長を後押しすると期待されています。例えば、Unitaidは疾病の迅速な解決策の発見に従事する大手保健機関です。2022年9月、Unitaidは結核の検出を促進するために3,000万米ドルの資金提供を開始しました。この資金は即日検査の開発を支援し、結核の新規診断技術の開発にも役立ちます。

同様に、世界基金は、結核、マラリア、HIVなどの感染症管理のための支援と資金提供を行っています。同組織は結核に対する世界の融資の約76％を提供し、結核管理のために約85億米ドルを投資しています。さらに2021年8月、世界基金はインドにおける結核の診断と予防を促進するための資金をFINDに提供しました。この投資は、結核の早期診断のための検査室の質を最適化し、同国の結核診断能力を向上させました。

さらに、結核感染の診断を促進するための検査への取り組みが世界的に高まっていることも、市場拡大を後押しすると予想されます。例えば、QIAGEN N.V.は2022年3月、QuantiFERON血液検査を発売以来1億件販売したと発表しました。この後、同社はQuantiFERONを世界中のより多くの患者に届けるために拡大することを決定しました。さらに、大手企業が市場シェア拡大のために行っている様々な戦略的取り組みも市場拡大を促進する要因の一つです。例えば、2021年10月、QIAGENは結核感染診断のためのQIAreach QuantiFERON-TB検査のCEマーク承認と展開を発表しました。

潜在性結核感染検出市場レポートハイライト：

• 検査タイプ別では、さまざまな公衆衛生当局によるIGRAの推奨が増加していることから、IGRA分野が予測期間中に最も速い速度で成長すると予想されます。
• 用途別では、HIV感染者における結核発症リスクの上昇により、PLHIVが2023年に最大の売上シェアを占めました。
• 診断研究所セグメントは、2023年に最も高い収益貢献者でした。一方、学術・研究機関セグメントは予測期間中に最も速いCAGRを示すと予想されます。
• アジア太平洋地域は、市場参入企業による投資の増加や研究活動の活発化により、予測期間中に最も速い成長を示すと予測されています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 潜在性結核感染検出市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場牽引要因分析
  • 市場抑制要因分析
  • 市場機会分析
  • 満たされていないニーズの分析
• 潜在性結核感染検出市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析
  • 価格分析
  • 数量分析

第4章 潜在性結核感染検出市場：ブランドの推定・動向分析

• 世界の潜在性結核感染検出市場：ブランドダッシュボード
• 世界の潜在性結核感染検出市場：ブランド変動分析
• 世界の潜在性結核感染検出市場：ブランド別、収益別
• QFT-Plus（クォンティフェロンTBゴールドプラス）
• その他

第5章 潜在性結核感染検出市場：検査タイプの推定・動向分析

• 世界の潜在性結核感染検出市場：検査タイプダッシュボード
• 世界の潜在性結核感染検出市場：検査タイプの変動分析
• 世界の潜在性結核感染検出市場：検査タイプ別、収益別
• ツベルクリン皮膚テスト（TST）
• インターフェロンガンマ遊離アッセイ（IGRA）

第6章 潜在性結核感染検出市場：用途の推定・動向分析

• 世界の潜在性結核感染検出市場：用途ダッシュボード
• 世界の潜在性結核感染検出市場：用途変動分析
• 世界の潜在性結核感染検出市場：用途別、収益別
• 肺結核の家庭内接触
• HIV感染者
• その他

第7章 潜在性結核感染検出市場：最終用途の推定・動向分析

• 世界の潜在性結核感染検出市場：最終用途ダッシュボード
• 世界の潜在性結核感染検出市場：最終用途変動分析
• 世界の潜在性結核感染検出市場：最終用途別、収益別
• 診断検査室
• 病院/診療所
• 学術・研究機関

第8章 潜在性結核感染検出市場：製品タイプ、技術、最終用途別の地域推定・動向分析

• 地域ダッシュボード
• 市場規模と予測動向分析、2018年から2030年：
• 北米
• 欧州
• アジア太平洋地域
• ラテンアメリカ
• 中東・アフリカ

第9章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 企業/競合の分類
• ベンダー情勢
  • 主なディストリビューターとチャネルパートナーのリスト
  • 主要顧客
  • 主要市場の企業シェア分析, 2023年
  • QIAGEN
  • BIOMERIEUX
  • Oxford Immunotec
  • SD Biosensor, INC.
  • Wantai BioPharm
  • Lionex GmbH
  • Sanofi
  • Serum Institute of India Pvt. Ltd
  • ARKRAY, Inc.
  • Par Pharmaceutical, Inc.

List of Tables

• Table 1 List of abbreviations
• Table 2 North America latent tuberculosis infection detection market, by region, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 3 North America latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 4 North America latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 5 North America latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 6 North America latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 7 U.S. latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 8 U.S. latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 9 U.S. latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 10 U.S. latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 11 Canada latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 12 Canada latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 13 Canada latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 14 Canada latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 15 Europe latent tuberculosis infection detection market, by region, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 16 Europe latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 17 Europe latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 18 Europe latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 19 Europe latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 20 Germany latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 21 Germany latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 22 Germany latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 23 Germany latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 24 UK latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 25 UK latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 26 UK latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 27 UK latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 28 France latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 29 France latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 30 France latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 31 France latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 32 Italy latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 33 Italy latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 34 Italy latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 35 Italy latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 36 Spain latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 37 Spain latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 38 Spain latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 39 Spain latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 40 Denmark latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 41 Denmark latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 42 Denmark latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 43 Denmark latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 44 Sweden latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 45 Sweden latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 46 Sweden latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 47 Sweden latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 48 Norway latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 49 Norway latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 50 Norway latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 51 Norway latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 52 Netherlands latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 53 Netherlands latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 54 Netherlands latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 55 Netherlands latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 56 Belgium latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 57 Belgium latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 58 Belgium latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 59 Belgium latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 60 Finland latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 61 Finland latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 62 Finland latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 63 Finland latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 64 Luxembourg latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 65 Luxembourg latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 66 Luxembourg latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 67 Luxembourg latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 68 Iceland latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 69 Iceland latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 70 Iceland latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 71 Iceland latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 72 Asia Pacific latent tuberculosis infection detection market, by region, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 73 Asia Pacific latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 74 Asia Pacific latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 75 Asia Pacific latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 76 Aisa Pacific latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 77 China latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 78 China latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 79 China latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 80 China latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 81 Japan latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 82 Japan latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 83 Japan latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 84 Japan latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 85 India latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 86 India latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 87 India latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 88 India latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 89 South Korea latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 90 South Korea latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 91 South Korea latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 92 South Korea latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 93 Australia latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 94 Australia latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 95 Australia latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 96 Australia latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 97 Thailand latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 98 Thailand latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 99 Thailand latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 100 Thailand latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 101 Singapore latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 102 Singapore latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 103 Singapore latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 104 Singapore latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 105 Bangladesh latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 106 Bangladesh latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 107 Bangladesh latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 108 Bangladesh latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 109 Latin America latent tuberculosis infection detection market, by region, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 110 Latin America latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 111 Latin America latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 112 Latin America latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 113 Latin America latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 114 Brazil latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 115 Brazil latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 116 Brazil latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 117 Brazil latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 118 Mexico latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 119 Mexico latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 120 Mexico latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 121 Mexico latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 122 Argentina latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 123 Argentina latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 124 Argentina latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 125 Argentina latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 126 MEA latent tuberculosis infection detection market, by region, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 127 MEA latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 128 MEA latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 129 MEA latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 130 MEA latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 131 South Africa latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 132 South Africa latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 133 South Africa latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 134 South Africa latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 135 Saudi Arabia latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 136 Saudi Arabia latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 137 Saudi Arabia latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 138 Saudi Arabia latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 139 UAE latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 140 UAE latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 141 UAE latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 142 UAE latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 143 Kuwait latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 144 Kuwait latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 145 Kuwait latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
• Table 146 Kuwait latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Primary interviews in North America
• Fig. 5 Primary interviews in Europe
• Fig. 6 Primary interviews in APAC
• Fig. 7 Primary interviews in Latin America
• Fig. 8 Primary interviews in MEA
• Fig. 9 Market research approaches
• Fig. 10 Value-chain-based sizing & forecasting
• Fig. 11 QFD modeling for market share assessment
• Fig. 12 Market formulation & validation
• Fig. 13 Latent tuberculosis infection detection market: market outlook
• Fig. 14 Latent tuberculosis infection detection competitive insights
• Fig. 15 Parent market outlook
• Fig. 16 Related/ancillary market outlook
• Fig. 17 Latent tuberculosis infection detection market driver impact
• Fig. 18 Latent tuberculosis infection detection market restraint impact
• Fig. 19 Latent tuberculosis infection detection market: Brand movement analysis
• Fig. 20 Latent tuberculosis infection detection market: Brand outlook and key takeaways
• Fig. 21 QFT-Plus (QuantiFERON-TB Gold Plus) market estimates and forecast, 2018 - 2030 (USD Million) (Number of tests in thousands)
• Fig. 22 Others estimates and forecast, 2018 - 2030 (USD Million) (Number of tests in thousands)
• Fig. 23 Latent tuberculosis infection detection market: Test type movement analysis
• Fig. 24 Latent tuberculosis infection detection market: Test type outlook and key takeaways
• Fig. 25 Tuberculin Skin Test (TST) market estimates and forecast, 2018 - 2030 (USD Million) (Number of tests in thousands)
• Fig. 26 Interferon Gamma Released Assay (IGRA) estimates and forecast, 2018 - 2030 (USD Million) (Number of tests in thousands)
• Fig. 27 Latent tuberculosis infection detection market: Application movement analysis
• Fig. 28 Latent tuberculosis infection detection market: Application outlook and key takeaways
• Fig. 29 Household contacts with pulmonary TB market estimates and forecast, 2018 - 2030 (USD Million) (Number of tests in thousands)
• Fig. 30 PLHIV estimates and forecast, 2018 - 2030 (USD Million) (Number of tests in thousands)
• Fig. 31 Others estimates and forecast, 2018 - 2030 (USD Million) (Number of tests in thousands)
• Fig. 32 Latent tuberculosis infection detection market: End-use movement analysis
• Fig. 33 Latent tuberculosis infection detection market: End-use outlook and key takeaways
• Fig. 34 Diagnostics laboratories estimates and forecast, 2018 - 2030 (USD Million) (Number of tests in thousands)
• Fig. 35 Hospital/Clinics market estimates and forecast, 2018 - 2030 (USD Million) (Number of tests in thousands)
• Fig. 36 Academic & research institutions market estimates and forecast, 2018 - 2030 (USD Million) (Number of tests in thousands)
• Fig. 37 Global latent tuberculosis infection detection market: Regional movement analysis
• Fig. 38 Global latent tuberculosis infection detection market: Regional outlook and key takeaways
• Fig. 39 Global latent tuberculosis infection detection market share and leading players
• Fig. 40 North America, by country
• Fig. 41 North America market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
• Fig. 42 U.S. key country dynamics
• Fig. 43 U.S. market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
• Fig. 44 Canada key country dynamics
• Fig. 45 Canada market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
• Fig. 46 Europe market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
• Fig. 47 UK key country dynamics
• Fig. 48 UK market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
• Fig. 49 Germany key country dynamics
• Fig. 50 Germany market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
• Fig. 51 France key country dynamics
• Fig. 52 France market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
• Fig. 53 Italy key country dynamics
• Fig. 54 Italy market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
• Fig. 55 Spain key country dynamics
• Fig. 56 Spain market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
• Fig. 57 Denmark key country dynamics
• Fig. 58 Denmark market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
• Fig. 59 Sweden key country dynamics
• Fig. 60 Sweden market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
• Fig. 61 Norway key country dynamics
• Fig. 62 Norway market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
• Fig. 63 Netherlands key country dynamics
• Fig. 64 Netherlands market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
• Fig. 65 Belgium key country dynamics
• Fig. 66 Belgium market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
• Fig. 67 Finland key country dynamics
• Fig. 68 Finland market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
• Fig. 69 Luxembourg key country dynamics
• Fig. 70 Luxembourg market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
• Fig. 71 Iceland key country dynamics
• Fig. 72 Iceland market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
• Fig. 73 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
• Fig. 74 China key country dynamics
• Fig. 75 China market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
• Fig. 76 Japan key country dynamics
• Fig. 77 Japan market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
• Fig. 78 India key country dynamics
• Fig. 79 India market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
• Fig. 80 Thailand key country dynamics
• Fig. 81 Thailand market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
• Fig. 82 South Korea key country dynamics
• Fig. 83 South Korea market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
• Fig. 84 Australia key country dynamics
• Fig. 85 Australia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
• Fig. 86 Singapore key country dynamics
• Fig. 87 Singapore market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
• Fig. 88 Bangladesh key country dynamics
• Fig. 89 Bangladesh market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
• Fig. 90 Latin America market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
• Fig. 91 Brazil key country dynamics
• Fig. 92 Brazil market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
• Fig. 93 Mexico key country dynamics
• Fig. 94 Mexico market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
• Fig. 95 Argentina key country dynamics
• Fig. 96 Argentina market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
• Fig. 97 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
• Fig. 98 South Africa key country dynamics
• Fig. 99 South Africa market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
• Fig. 100 Saudi Arabia key country dynamics
• Fig. 101 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
• Fig. 102 UAE key country dynamics
• Fig. 103 UAE market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
• Fig. 104 Kuwait key country dynamics
• Fig. 105 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
• Fig. 106 Market share of key market players - Latent tuberculosis infection detection market

Latent Tuberculosis Infection Detection Market Growth & Trends:

The global latent tuberculosis infection detection market size is expected to reach USD 2.63 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.44% from 2024 to 2030. The increased risk of developing active disease from latent tuberculosis infection (LTBI) coupled with the surge in the geriatric population globally is one of the major driving factors for the market growth. In addition, rising awareness about TB detection and various government initiatives for effective diagnosis and screening of tuberculosis infection is another factor contributing to market expansion. For instance, in July 2021, the UKHSA and NHS of England launched a 5-year plan to decrease TB cases in the country.

The market growth is fueled by the increase in the geriatric population across the globe. For instance, according to the elderly population report of America's Health Rankings 2021, more than 54 million population aged more than 65 years in the U.S. which accounts for 16.5% of the country's population. The geriatric population is highly susceptible to developing latent TB infection. Policymakers and public health officials are making improvements in policies to improve the health of older in the country.

Furthermore, ongoing funding activities by leading organizations to promote the diagnosis and testing for tuberculosis are also expected to fuel market growth. For instance, Unitaid is a leading health agency engaged in discovering quick solutions for diseases. In September 2022, the Unitaid launched funding of USD 30 million to boost tuberculosis detection. This funding will support the development of same-day tests and also help in the development of novel diagnostic technologies for tuberculosis.

Similarly, the Global Fund provides support and funding for the management of infectious diseases such as tuberculosis, malaria, and HIV. The organization provides around 76% of global financing for tuberculosis and it has invested around USD 8.5 billion for the management of tuberculosis. Furthermore, in August 2021, the Global Fund provide funds to FIND for the advancement of TB diagnosis and prevention in India. This investment optimized laboratory quality for early diagnosis of TB and improved tuberculosis diagnostic capacity in the country.

In addition, the rising testing efforts globally to promote the diagnosis of TB infection are expected to support market expansion. For instance, in March 2022, QIAGEN N.V. announced that the company has sold 100 million QuantiFERON blood tests since its launch. After this, the company decided to expand QuantiFERON to reach more patients across the globe. Moreover, various strategic initiatives undertaken by leading players to enhance their market share are another factor facilitating market expansion. For instance, in October 2021, QIAGEN announced CE mark approval and roll-out of the QIAreach QuantiFERON-TB test for tuberculosis infection diagnosis.

Latent Tuberculosis Infection Detection Market Report Highlights:

• In test type, the IGRA segment is expected to grow at the fastest rate over the forecast period owing to increasing recommendations for IGRAs from various public health authorities
• Based on application segment, the PLHIV accounted for the largest revenue share in 2023 due to the rising risk of developing TB in people suffering from HIV infection
• The diagnostic laboratories segment was the highest revenue contributor in 2023. Whereas the academic and research institutions segment is expected to exhibit the fastest CAGR during the projected period
• Asia Pacific is expected to exhibit the fastest growth over the forecast period due to the rising investments by market players and increasing research activities in the region

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Brand
  • 1.2.2. Test Type
  • 1.2.3. Application
  • 1.2.4. End-use
  • 1.2.5. Regional scope
  • 1.2.6. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Brand and test type outlook
  • 2.2.2. Application and end-use outlook
  • 2.2.3. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Latent Tuberculosis Infection Detection Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing risk of developing active tuberculosis infection from LTBI
    • 3.2.1.2. Increasing funding programs to promote TB diagnosis
    • 3.2.1.3. Favorable government initiatives for combating TB
    • 3.2.1.4. Surge in geriatric population
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Presence of stringent rules and regulations pertaining to diagnosis
  • 3.2.3. Market opportunity analysis
  • 3.2.4. Unmet need analysis
• 3.3. Latent Tuberculosis Infection Detection Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environment landscape
  • 3.3.3. Pricing Analysis
  • 3.3.4. Volume Analysis

Chapter 4. Latent Tuberculosis Infection Detection Market: Brand Estimates & Trend Analysis

• 4.1. Global Latent Tuberculosis Infection Detection Market: Brand Dashboard
• 4.2. Global Latent Tuberculosis Infection Detection Market: Brand Movement Analysis
• 4.3. Global Latent Tuberculosis Infection Detection Market by brand, Revenue
• 4.4. QFT-Plus (QuantiFERON-TB Gold Plus)
  • 4.4.1. QFT-Plus (QuantiFERON-TB Gold Plus) market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Others
  • 4.5.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Latent Tuberculosis Infection Detection Market: Test Type Estimates & Trend Analysis

• 5.1. Global Latent Tuberculosis Infection Detection Market: Test Type Dashboard
• 5.2. Global Latent Tuberculosis Infection Detection Market: Test Type Movement Analysis
• 5.3. Global Latent Tuberculosis Infection Detection Market by Test Type, Revenue
• 5.4. Tuberculin Skin Test (TST)
  • 5.4.1. Tuberculin Skin Test (TST) market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Interferon Gamma Released Assay (IGRA)
  • 5.5.1. Interferon Gamma Released Assay (IGRA) market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Latent Tuberculosis Infection Detection Market: Application Estimates & Trend Analysis

• 6.1. Global Latent Tuberculosis Infection Detection Market: Application Dashboard
• 6.2. Global Latent Tuberculosis Infection Detection Market: Application Movement Analysis
• 6.3. Global Latent Tuberculosis Infection Detection Market by Application, Revenue
• 6.4. Household Contacts with Pulmonary TB
  • 6.4.1. Household contacts with pulmonary TB market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. PLHIV
  • 6.5.1. PLHIV market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Others
  • 6.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Latent Tuberculosis Infection Detection Market: End-use Estimates & Trend Analysis

• 7.1. Global Latent Tuberculosis Infection Detection Market: End-use Dashboard
• 7.2. Global Latent Tuberculosis Infection Detection Market: End-use Movement Analysis
• 7.3. Global Latent Tuberculosis Infection Detection Market by End-use, Revenue
• 7.4. Diagnostic Laboratories
  • 7.4.1. Diagnostic laboratories market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Hospitals/Clinics
  • 7.5.1. Hospitals/Clinics market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Academic & Research Institutions
  • 7.6.1. Academic & research institutions market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Latent Tuberculosis Infection Detection Market: Regional Estimates & Trend Analysis by Product Type, Technology, and End-use

• 8.1. Regional Dashboard
• 8.2. Market Size & Forecasts Trend Analysis, 2018 to 2030:
• 8.3. North America
  • 8.3.1. U.S.
    • 8.3.1.1. Key country dynamics
    • 8.3.1.2. Regulatory framework/ reimbursement structure
    • 8.3.1.3. Competitive scenario
    • 8.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
  • 8.3.2. Canada
    • 8.3.2.1. Key country dynamics
    • 8.3.2.2. Regulatory framework/ reimbursement structure
    • 8.3.2.3. Competitive scenario
    • 8.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
• 8.4. Europe
  • 8.4.1. UK
    • 8.4.1.1. Key country dynamics
    • 8.4.1.2. Regulatory framework/ reimbursement structure
    • 8.4.1.3. Competitive scenario
    • 8.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
  • 8.4.2. Germany
    • 8.4.2.1. Key country dynamics
    • 8.4.2.2. Regulatory framework/ reimbursement structure
    • 8.4.2.3. Competitive scenario
    • 8.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
  • 8.4.3. France
    • 8.4.3.1. Key country dynamics
    • 8.4.3.2. Regulatory framework/ reimbursement structure
    • 8.4.3.3. Competitive scenario
    • 8.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
  • 8.4.4. Italy
    • 8.4.4.1. Key country dynamics
    • 8.4.4.2. Regulatory framework/ reimbursement structure
    • 8.4.4.3. Competitive scenario
    • 8.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
  • 8.4.5. Spain
    • 8.4.5.1. Key country dynamics
    • 8.4.5.2. Regulatory framework/ reimbursement structure
    • 8.4.5.3. Competitive scenario
    • 8.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
  • 8.4.6. Norway
    • 8.4.6.1. Key country dynamics
    • 8.4.6.2. Regulatory framework/ reimbursement structure
    • 8.4.6.3. Competitive scenario
    • 8.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
  • 8.4.7. Sweden
    • 8.4.7.1. Key country dynamics
    • 8.4.7.2. Regulatory framework/ reimbursement structure
    • 8.4.7.3. Competitive scenario
    • 8.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
  • 8.4.8. Denmark
    • 8.4.8.1. Key country dynamics
    • 8.4.8.2. Regulatory framework/ reimbursement structure
    • 8.4.8.3. Competitive scenario
    • 8.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
  • 8.4.9. Netherlands
    • 8.4.9.1. Key country dynamics
    • 8.4.9.2. Regulatory framework/ reimbursement structure
    • 8.4.9.3. Competitive scenario
    • 8.4.9.4. Netherlands market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
  • 8.4.10. Belgium
    • 8.4.10.1. Key country dynamics
    • 8.4.10.2. Regulatory framework/ reimbursement structure
    • 8.4.10.3. Competitive scenario
    • 8.4.10.4. Belgium market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
  • 8.4.11. Finland
    • 8.4.11.1. Key country dynamics
    • 8.4.11.2. Regulatory framework/ reimbursement structure
    • 8.4.11.3. Competitive scenario
    • 8.4.11.4. Finland market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
  • 8.4.12. Luxembourg
    • 8.4.12.1. Key country dynamics
    • 8.4.12.2. Regulatory framework/ reimbursement structure
    • 8.4.12.3. Competitive scenario
    • 8.4.12.4. Luxembourg market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
  • 8.4.13. Iceland
    • 8.4.13.1. Key country dynamics
    • 8.4.13.2. Regulatory framework/ reimbursement structure
    • 8.4.13.3. Competitive scenario
    • 8.4.13.4. Iceland market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
• 8.5. Asia Pacific
  • 8.5.1. Japan
    • 8.5.1.1. Key country dynamics
    • 8.5.1.2. Regulatory framework/ reimbursement structure
    • 8.5.1.3. Competitive scenario
    • 8.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
  • 8.5.2. China
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Regulatory framework/ reimbursement structure
    • 8.5.2.3. Competitive scenario
    • 8.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
  • 8.5.3. India
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Regulatory framework/ reimbursement structure
    • 8.5.3.3. Competitive scenario
    • 8.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
  • 8.5.4. Australia
    • 8.5.4.1. Key country dynamics
    • 8.5.4.2. Regulatory framework/ reimbursement structure
    • 8.5.4.3. Competitive scenario
    • 8.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
  • 8.5.5. South Korea
    • 8.5.5.1. Key country dynamics
    • 8.5.5.2. Regulatory framework/ reimbursement structure
    • 8.5.5.3. Competitive scenario
    • 8.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
  • 8.5.6. Thailand
    • 8.5.6.1. Key country dynamics
    • 8.5.6.2. Regulatory framework/ reimbursement structure
    • 8.5.6.3. Competitive scenario
    • 8.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
  • 8.5.7. Singapore
    • 8.5.7.1. Key country dynamics
    • 8.5.7.2. Regulatory framework/ reimbursement structure
    • 8.5.7.3. Competitive scenario
    • 8.5.7.4. Singapore market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
  • 8.5.8. Bangladesh
    • 8.5.8.1. Key country dynamics
    • 8.5.8.2. Regulatory framework/ reimbursement structure
    • 8.5.8.3. Competitive scenario
    • 8.5.8.4. Bangladesh market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
• 8.6. Latin America
  • 8.6.1. Brazil
    • 8.6.1.1. Key country dynamics
    • 8.6.1.2. Regulatory framework/ reimbursement structure
    • 8.6.1.3. Competitive scenario
    • 8.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
  • 8.6.2. Mexico
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Regulatory framework/ reimbursement structure
    • 8.6.2.3. Competitive scenario
    • 8.6.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
  • 8.6.3. Argentina
    • 8.6.3.1. Key country dynamics
    • 8.6.3.2. Regulatory framework/ reimbursement structure
    • 8.6.3.3. Competitive scenario
    • 8.6.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
• 8.7. MEA
  • 8.7.1. South Africa
    • 8.7.1.1. Key country dynamics
    • 8.7.1.2. Regulatory framework/ reimbursement structure
    • 8.7.1.3. Competitive scenario
    • 8.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
  • 8.7.2. Saudi Arabia
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Regulatory framework/ reimbursement structure
    • 8.7.2.3. Competitive scenario
    • 8.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
  • 8.7.3. UAE
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Regulatory framework/ reimbursement structure
    • 8.7.3.3. Competitive scenario
    • 8.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
  • 8.7.4. Kuwait
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Regulatory framework/ reimbursement structure
    • 8.7.4.3. Competitive scenario
    • 8.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)

Chapter 9. Competitive Landscape

• 9.1. Recent Developments & Impact Analysis, By Key Market Participants
• 9.2. Company/Competition Categorization
• 9.3. Vendor Landscape
  • 9.3.1. List of key distributors and channel partners
  • 9.3.2. Key customers
  • 9.3.3. Key company market share analysis, 2023
  • 9.3.4. QIAGEN
    • 9.3.4.1. Company overview
    • 9.3.4.2. Financial performance
    • 9.3.4.3. Product benchmarking
    • 9.3.4.4. Strategic initiatives
  • 9.3.5. BIOMERIEUX
    • 9.3.5.1. Company overview
    • 9.3.5.2. Financial performance
    • 9.3.5.3. Product benchmarking
    • 9.3.5.4. Strategic initiatives
  • 9.3.6. Oxford Immunotec
    • 9.3.6.1. Company overview
    • 9.3.6.2. Financial performance
    • 9.3.6.3. Product benchmarking
    • 9.3.6.4. Strategic initiatives
  • 9.3.7. SD Biosensor, INC.
    • 9.3.7.1. Company overview
    • 9.3.7.2. Financial performance
    • 9.3.7.3. Product benchmarking
    • 9.3.7.4. Strategic initiatives
  • 9.3.8. Wantai BioPharm
    • 9.3.8.1. Company overview
    • 9.3.8.2. Financial performance
    • 9.3.8.3. Product benchmarking
    • 9.3.8.4. Strategic initiatives
  • 9.3.9. Lionex GmbH
    • 9.3.9.1. Company overview
    • 9.3.9.2. Financial performance
    • 9.3.9.3. Product benchmarking
    • 9.3.9.4. Strategic initiatives
  • 9.3.10. Sanofi
    • 9.3.10.1. Company overview
    • 9.3.10.2. Financial performance
    • 9.3.10.3. Product benchmarking
    • 9.3.10.4. Strategic initiatives
  • 9.3.11. Serum Institute of India Pvt. Ltd
    • 9.3.11.1. Company overview
    • 9.3.11.2. Financial performance
    • 9.3.11.3. Product benchmarking
    • 9.3.11.4. Strategic initiatives
  • 9.3.12. ARKRAY, Inc.
    • 9.3.12.1. Company overview
    • 9.3.12.2. Financial performance
    • 9.3.12.3. Product benchmarking
    • 9.3.12.4. Strategic initiatives
  • 9.3.13. Par Pharmaceutical, Inc.
    • 9.3.13.1. Company overview
    • 9.3.13.2. Financial performance
    • 9.3.13.3. Product benchmarking
    • 9.3.13.4. Strategic initiatives